Viewing data from:

CLOMIPRAMINE HYDROCHLORIDE

ANDA

CLOMIPRAMINE HYDROCHLORIDE | A211364 | LEADING PHARMA LLC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: ANAFRANIL(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 2 NDCs

Highest NADAC/Unit

$0.2522

per ea

Lowest NADAC/Unit

$0.2031

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69315016601CLOMIPRAMINE 50 MG CAPSULE	$0.2522	EA	Generic	—	2026-10-21
69315016701CLOMIPRAMINE 25 MG CAPSULE	$0.2031	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$52.50

Highest Price

$52.50

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
69315-0165-01CLOMIPRAMINE HCL 75MG CAP	$52.50	FSS	AvKare, LLC	06/14/2028
69315-0166-01CLOMIPRAMINE HCL 50MG CAP	$52.50	FSS	AvKare, LLC	06/14/2028
69315-0167-01CLOMIPRAMINE HCL 25MG CAP	$52.50	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain7 active DMFs2 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

LUNDBECK PHARMACEUTICALS ITALY SPACLOMIPRAMINE HYDROCHLORIDE

DMF 88641990

SIGMA ALDRICH IRELAND LTDCLOMIPRAMINE HYDROCHLORIDE

DMF 109491994

TARO PHARMACEUTICAL INDUSTRIES LTDCLOMIPRAMINE HYDROCHLORIDE USP

DMF 130211998

BIOPHORE INDIA PHARMACEUTICALS PVT LTDCLOMIPRAMINE HYDROCHLORIDE

DMF 308142016

RL FINE CHEM PVT LTDCLOMIPRAMINE HYDROCHLORIDE

DMF 319422017

SUN PHARMACEUTICAL INDUSTRIES LTDCLOMIPRAMINE HYDROCHLORIDE USP

DMF 329962018

MANKIND PHARMA LTDCLOMIPRAMINE HYDROCHLORIDE USP

DMF 349352020

IROPHARM LTDInactiveCLOMIPRAMINE HYDROCHLORIDE

DMF 80471989

EVONIK TECHNOCHEMIE GMBHInactiveCLOMIPRAMINE HYDROCHLORIDE

DMF 131271998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 25MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Feb 7, 2020

No patent or exclusivity listings for this strength.

#002 — 50MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Feb 7, 2020

#003 — 75MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Feb 7, 2020